Kit For The Preparation Of Indium In 111 Pentetreotide
Product Images NDC 45567-0755

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Kit For The Preparation Of Indium In 111 Pentetreotide (NDC 45567-0755). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Pentetreotide 01)

Chemical structure diagram of Indium In 111 Pentetreotide, illustrating the molecular components including carboxyl groups, amino acid residues (D-Phe, Cys, Phe, D-Trp, Lys, Thr(ol), Cys, Thr), and their connectivity.*

FDA Label Image

Pdp-01 (Pentetreotide 02)

Packaging label for Kit for the Preparation of Indium In 111 Pentetreotide by Sun Pharmaceutical Industries, Inc., NDC 45567-0755. The label includes kit contents, chemical amounts per vial, storage instructions, and a caution symbol for radioactive materials. It specifies diagnostic intravenous use, preparation timing, and distributor information.*

FDA Label Image

Pdp-02 (Pentetreotide 03)

Packaging label for Kit for the Preparation of Indium In 111 Pentetreotide Injection Reaction Vial Pack by Sun Pharmaceutical Industries, Inc. The label includes storage instructions to refrigerate at 2° to 8°C and protect from light. It lists kit contents including sterile kit components, reaction vial contents such as Pentetreotide 10 mcg, Gentisic Acid, Sodium Citrate Anhydrous, Citric Acid Anhydrous, Inositol, and mentions Rx only with pH adjustment information.*

FDA Label Image

Pdp-03 (Pentetreotide 04)

Label for Kit for the Preparation of Indium In 111 Pentetreotide Injection Reaction Vial by Sun Pharmaceutical Industries, Inc. It lists vial contents including Pentetreotide 10 mcg, Gentisic Acid 2 mg, Sodium Citrate Anhydrous 4.9 mg, Citric Acid Anhydrous 0.37 mg, and Inositol 10 mg. The label includes storage instructions to refrigerate at 2° to 8°C and to protect from light, and states the product is for intravenous administration and Rx only.*

FDA Label Image

Pdp-04 (Pentetreotide 05)

Label for Indium In 111 Chloride Solution, a sterile, non-pyrogenic intravenous solution containing 111 MBq/mL (3 mCi/mL) of aqueous indium In-111 chloride and ferric chloride. The 1.1 mL vial is labeled with product number 2055 and manufactured for Sun Pharmaceutical Industries, Inc. by GE Healthcare Medi-Physics, Inc. The label features radioactive material caution.*

FDA Label Image

Pdp-05 (Pentetreotide 06)

Label for Indium In 111 Chloride Solution, a sterile, non-pyrogenic solution without bacteriostatic preservative for intravenous use. The vial contains 1.1 mL of the solution at a specific concentration of 111 MBq/mL (3 mCi/mL). The total activity in the vial is 122 MBq (3.3 mCi). The product is manufactured by GE Healthcare Med-Physics, Inc. and labeled for Sun Pharmaceutical Industries, Inc. The label includes a radioactivity caution symbol and handling warnings.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.